dc.contributor.author | Evensen, Ann E. | eng |
dc.contributor.author | Elliott, Marguerite | eng |
dc.contributor.author | Hooper-Lane, Christopher | eng |
dc.date.issued | 2010 | eng |
dc.description.abstract | Patients who have coronary heart disease (CHD) or are at high risk for CHD should aim for a low-density lipoprotein (LDL) target of <100 mg/dL. An LDL target of <70 mg/dL is an option for very-high-risk patients (strength of recommendation [SOR]: C, expert opinion). The evidence also indicates that high-risk patients benefit from a statin--preferably in high doses--regardless of their baseline LDL or degree of LDL reduction with treatment (SOR: A, a large randomized controlled trial [RCT] and meta-analyses). | eng |
dc.identifier.uri | http://hdl.handle.net/10355/9436 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2010 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 59, no. 12 (December 2010): 706-708. | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | cholesterol management | eng |
dc.subject | risk factors | eng |
dc.subject.lcsh | Low density lipoproteins | eng |
dc.subject.lcsh | Coronary heart disease | eng |
dc.subject.lcsh | Statins (Cardiovascular agents) | eng |
dc.title | Which patients benefit from lowering LDL to <100 mg/dL? | eng |
dc.type | Article | eng |